ROYCE & ASSOCIATES LP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q2 2020$177,000
+38.3%
12,000
-61.4%
0.00%0.0%
Q1 2020$128,000
-14.7%
31,1000.0%0.00%
+100.0%
Q4 2019$150,000
-20.2%
31,1000.0%0.00%
-50.0%
Q3 2019$188,000
-61.9%
31,100
-59.1%
0.00%
-50.0%
Q2 2019$494,000
-8.5%
76,1000.0%0.00%
-20.0%
Q1 2019$540,000
+45.9%
76,1000.0%0.01%
+66.7%
Q4 2018$370,000
-43.3%
76,100
-14.2%
0.00%
-25.0%
Q3 2018$652,000
+15.2%
88,7000.0%0.00%0.0%
Q2 2018$566,000
+0.7%
88,700
-14.2%
0.00%0.0%
Q1 2018$562,000
+104.4%
103,400
+56.9%
0.00%
+100.0%
Q4 2017$275,00065,9000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders